These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26460684)

  • 1. Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors.
    Zhang J; Yang Q; Cross JB; Romero JA; Poutsiaka KM; Epie F; Bevan D; Wang B; Zhang Y; Chavan A; Zhang X; Moy T; Daniel A; Nguyen K; Chamberlain B; Carter N; Shotwell J; Silverman J; Metcalf CA; Ryan D; Lippa B; Dolle RE
    J Med Chem; 2015 Nov; 58(21):8503-12. PubMed ID: 26460684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity.
    Yule IA; Czaplewski LG; Pommier S; Davies DT; Narramore SK; Fishwick CW
    Eur J Med Chem; 2014 Oct; 86():31-8. PubMed ID: 25137573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.
    Manchester JI; Dussault DD; Rose JA; Boriack-Sjodin PA; Uria-Nickelsen M; Ioannidis G; Bist S; Fleming P; Hull KG
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5150-6. PubMed ID: 22814212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
    Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
    J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
    Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
    Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors.
    Chiriac AI; Kloss F; Krämer J; Vuong C; Hertweck C; Sahl HG
    J Antimicrob Chemother; 2015 Sep; 70(9):2576-88. PubMed ID: 26174721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
    Basarab GS; Manchester JI; Bist S; Boriack-Sjodin PA; Dangel B; Illingworth R; Sherer BA; Sriram S; Uria-Nickelsen M; Eakin AE
    J Med Chem; 2013 Nov; 56(21):8712-35. PubMed ID: 24098982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Biological Evaluation of Novel DNA Gyrase-Inhibiting Spiropyrimidinetriones as Potent Antibiotics for Treatment of Infections Caused by Multidrug-Resistant Gram-Positive Bacteria.
    Shi C; Zhang Y; Wang T; Lu W; Zhang S; Guo B; Chen Q; Luo C; Zhou X; Yang Y
    J Med Chem; 2019 Mar; 62(6):2950-2973. PubMed ID: 30698430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents.
    Khan T; Sankhe K; Suvarna V; Sherje A; Patel K; Dravyakar B
    Biomed Pharmacother; 2018 Jul; 103():923-938. PubMed ID: 29710509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase.
    Gibson EG; Bax B; Chan PF; Osheroff N
    ACS Infect Dis; 2019 Apr; 5(4):570-581. PubMed ID: 30757898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus.
    Phillips JW; Goetz MA; Smith SK; Zink DL; Polishook J; Onishi R; Salowe S; Wiltsie J; Allocco J; Sigmund J; Dorso K; Lee S; Skwish S; de la Cruz M; Martín J; Vicente F; Genilloud O; Lu J; Painter RE; Young K; Overbye K; Donald RG; Singh SB
    Chem Biol; 2011 Aug; 18(8):955-65. PubMed ID: 21867911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragments.
    Kolarič A; Novak D; Weiss M; Hrast M; Zdovc I; Anderluh M; Minovski N
    Future Med Chem; 2019 May; 11(9):935-945. PubMed ID: 31140866
    [No Abstract]   [Full Text] [Related]  

  • 13. Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity.
    Surivet JP; Zumbrunn C; Rueedi G; Hubschwerlen C; Bur D; Bruyère T; Locher H; Ritz D; Keck W; Seiler P; Kohl C; Gauvin JC; Mirre A; Kaegi V; Dos Santos M; Gaertner M; Delers J; Enderlin-Paput M; Boehme M
    J Med Chem; 2013 Sep; 56(18):7396-415. PubMed ID: 23968485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The overview of development of novel bacterial topoisomerase inhibitors effective against multidrug-resistant bacteria in an academic environment: From early hits to in vivo active antibacterials.
    Zorman M; Hrast Rambaher M; Kokot M; Minovski N; Anderluh M
    Eur J Pharm Sci; 2024 Jan; 192():106632. PubMed ID: 37949194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
    Tomašič T; Katsamakas S; Hodnik Ž; Ilaš J; Brvar M; Solmajer T; Montalvão S; Tammela P; Banjanac M; Ergović G; Anderluh M; Peterlin Mašič L; Kikelj D
    J Med Chem; 2015 Jul; 58(14):5501-21. PubMed ID: 26098163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus.
    Janupally R; Jeankumar VU; Bobesh KA; Soni V; Devi PB; Pulla VK; Suryadevara P; Chennubhotla KS; Kulkarni P; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Nov; 22(21):5970-87. PubMed ID: 25288496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation.
    Zidar N; Macut H; Tomašič T; Brvar M; Montalvão S; Tammela P; Solmajer T; Peterlin Mašič L; Ilaš J; Kikelj D
    J Med Chem; 2015 Aug; 58(15):6179-94. PubMed ID: 26126187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided identification of novel 3,5-substituted rhodanine derivatives with activity against Staphylococcus aureus DNA gyrase.
    Werner MM; Li Z; Zauhar RJ
    Bioorg Med Chem; 2014 Apr; 22(7):2176-87. PubMed ID: 24629449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2).
    Singh SB; Kaelin DE; Wu J; Miesel L; Tan CM; Black T; Nargund R; Meinke PT; Olsen DB; Lagrutta A; Lu J; Patel S; Rickert KW; Smith RF; Soisson S; Sherer E; Joyce LA; Wei C; Peng X; Wang X; Fukuda H; Kishii R; Takei M; Takano H; Shibasaki M; Yajima M; Nishimura A; Shibata T; Fukuda Y
    Bioorg Med Chem Lett; 2015 May; 25(9):1831-5. PubMed ID: 25851938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety.
    Li L; Okumu A; Dellos-Nolan S; Li Z; Karmahapatra S; English A; Yalowich JC; Wozniak DJ; Mitton-Fry MJ
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2477-2480. PubMed ID: 29871847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.